Brittle bone disease, known medically as osteogenesis imperfecta (OI), is a genetic condition that makes bones extremely fragile and prone to fracturing. It affects roughly 1 in every 16,000 to 20,000 births. Some people experience only a handful of fractures in their lifetime, while others may have hundreds, sometimes starting before birth. The condition ranges from mild to fatal, depending on the type and the specific genetic change involved.
What Causes Brittle Bone Disease
OI is caused by mutations in the genes responsible for producing type I collagen, the main structural protein in bone, skin, tendons, and the whites of the eyes. Collagen works like the scaffolding that gives bones their flexibility and strength. In OI, either the body makes too little collagen or makes collagen with an abnormal structure.
The two genes most commonly involved are COL1A1 and COL1A2. When a mutation simply reduces the amount of collagen the body produces, the result is usually a milder form of the disease. The bones are structurally normal but there just isn’t enough material to build them properly. When a mutation changes the shape of the collagen molecule itself, the consequences are typically more severe. The misshapen protein gets incorporated into the bone matrix, actively weakening it from the inside. This is why two people with OI can have dramatically different experiences: one might break a bone only during a fall, while another fractures a rib while being picked up.
Collagen type I is built from three protein chains twisted together in a tight helix. The amino acid glycine, the smallest one available, must sit at every third position in the chain for the helix to fold properly. When a mutation swaps glycine for a larger amino acid, the chain can’t fold correctly, and the resulting collagen is defective. This single molecular detail explains much of the disease.
Types and Severity
OI is classified into several types, with four being the most commonly recognized. They range from a mild form that many people live with into adulthood to a form that is fatal at or before birth.
- Type I is the mildest and most common form. Bones break more easily than normal, mostly from mild to moderate trauma, and most fractures occur before puberty. People with type I often have a blue, purple, or gray tint to the whites of their eyes. Life expectancy is typically normal or near-normal.
- Type II is the most severe form. Infants have bones that are already fractured and misshapen before birth, along with underdeveloped lungs and a narrow chest. Most babies with type II are stillborn or die shortly after birth from breathing failure.
- Type III is the most severe form compatible with survival. Bones fracture extremely easily, often before birth or in early infancy. Rib fractures can cause life-threatening breathing problems. People with type III typically have short stature, progressive bone deformity, and a blue or gray tint to the whites of their eyes.
- Type IV falls between type I and type III in severity. Bones break easily, sometimes before birth, with most fractures happening before puberty. Hearing loss and changes to the strength or color of teeth are possible.
Life expectancy varies widely. People with type I often live a full lifespan. Type III carries more complications, particularly respiratory ones, that can shorten life. Type II is almost always fatal in the newborn period.
Symptoms Beyond Fragile Bones
Because type I collagen is found throughout the body, OI affects more than just the skeleton. Four hallmark features define the condition: increased fracture risk with decreased bone mass, a blue or gray tint to the sclera (the whites of the eyes), dental problems, and hearing loss.
The blue sclera occurs because the collagen layer in the eye is thinner than normal, allowing the underlying blood vessels to show through. Dental issues, called dentinogenesis imperfecta, happen when the inner layer of the teeth (the dentin) forms abnormally while the outer enamel remains normal. Teeth may appear translucent, discolored, or prone to chipping. Hearing loss can develop in adolescence or adulthood, often due to changes in the tiny bones of the middle ear.
Other common features include loose joints and unusually flexible ligaments, short stature, bowing of the long bones, easy bruising, and in some cases distinctive facial features. Routine blood tests are usually normal, though a bone enzyme called alkaline phosphatase may be mildly elevated.
How It’s Diagnosed
There is no single test for OI. Diagnosis relies on a combination of clinical signs, family history, bone density scans, and X-ray findings. A doctor evaluating for OI will look for the characteristic pattern of fragile bones, blue sclera, dental changes, and hearing loss, along with imaging that shows reduced bone density or unusual fracture patterns.
Genetic testing can identify mutations in the collagen genes, but the broad range of possible mutations means a negative test doesn’t always rule out the condition. In uncertain cases, a skin biopsy can be analyzed for collagen quality, which picks up about 80% of type IV cases. Severe forms, particularly type II, can be detected on prenatal ultrasound as early as 16 weeks of pregnancy. If OI is suspected prenatally, DNA analysis of a tissue sample from the placenta can confirm the diagnosis.
Medication for Bone Strength
The most widely used medications for OI are bisphosphonates, drugs that slow the breakdown of bone and help increase bone density. These are the same class of medication used for osteoporosis in older adults, but they’re given to children and adults with OI specifically to strengthen fragile bones.
Research consistently shows that bisphosphonates increase bone mineral density, particularly in the spine. A Cochrane review of 14 clinical trials found that every trial measuring bone density reported significant improvements after treatment. The picture for fracture reduction is less clear-cut. Some individual studies found meaningful reductions: one reported a 31% drop in the relative risk of long-bone fractures in children treated with oral bisphosphonates, and another found fractures occurred in 31% of children on medication compared to 49% on placebo. However, when data from multiple trials were pooled together, the overall reduction in fractures did not always reach statistical significance. Importantly, no study found that bisphosphonates increased fracture rates. The takeaway is that these drugs reliably strengthen bone, and they likely reduce fractures, but the evidence isn’t as definitive on that second point as patients and families would like.
Surgery for Bone Deformity
For people with moderate to severe OI, surgery to insert metal rods inside the long bones is a standard treatment. These intramedullary rods act as internal splints, reinforcing bones that fracture repeatedly or have become bowed and deformed. The procedure is most commonly performed on the legs to support walking.
Telescopic rods, which lengthen as a child grows, have a clear advantage over fixed-length rods because they require fewer revision surgeries over time. That said, complications are still common, and additional surgeries should be expected. Plates and screws alone are not recommended for OI bones because the bone is too fragile to hold them, though plates are sometimes used alongside rods for added stability.
Physical Therapy and Daily Life
The central goal of managing OI is reducing pain and fracture risk while keeping the body as mobile and functional as possible. Physical therapy plays a critical role, especially for children. A therapist working with someone who has OI follows a developmental sequence: building head and trunk control first, then seated balance, then progressing toward walking. Exercises focus on strengthening muscles (particularly the trunk and abdomen), improving range of motion, and training balance and coordination.
Rehabilitation after a fracture typically starts with gentle passive movement and gradually progresses to active exercises. The emphasis is not just on getting someone walking again but on building self-care skills and compensating strategies that improve independence. Swimming and water-based exercise are particularly well-suited to OI because water supports body weight while allowing muscles to strengthen. Early encouragement to move within a safe environment, even soon after a fracture, leads to better outcomes than prolonged immobilization, which can further weaken already fragile bones.
For children with more severe forms, powered wheelchairs, adaptive equipment, and modified school environments become part of daily life. The goal is always to maximize what someone can do safely rather than to restrict activity out of fear of fractures.